Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value: $1.201B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Karuna Therapeutics Inc | 2,073,124 | $262M | 21.8% | $32.21 | — | COM | 48576A100 |
| NTRA | Natera Inc | 3,102,960 | $110M | 9.2% | $9.81 | +277.5% | COM | 632307104 |
| — | Cincor Pharma Inc | 5,573,949 | $105M | 8.7% | $17.54 | — | COM | 17240Y109 |
| — | Aerovate Therapeutics Inc | 3,758,686 | $58.75M | 4.9% | $22.83 | — | COM | 008064107 |
| ASND | Ascendis Pharma A/S | 499,824 | $46.46M | 3.9% | $69.98 | — | SPONSORED ADR | 04351P101 |
| VERA | Vera Therapeutics Inc | 3,181,442 | $43.3M | 3.6% | $16.04 | +8.8% | CL A | 92337R101 |
| XLV | Health Care Select Sector SPDR Fund | 300,000 | $38.47M | 3.2% | — | — | Put | 81369Y209 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $33.2M | 2.8% | $26.75 | — | COM | 984241109 |
| MRK | Merck & Co Inc | 360,961 | $32.91M | 2.7% | $79.21 | 0.0% | COM | 58933Y105 |
| NVO | Novo-Nordisk A S | 273,873 | $30.52M | 2.5% | $111.43 | — | ADR | 670100205 |
| XBI | SPDR S&P Biotech ETF | 400,000 | $29.71M | 2.5% | — | — | Put | 78464A870 |
| UTHR | United Therapeutics Corp | 106,379 | $25.07M | 2.1% | $129.60 | +56.9% | COM | 91307C102 |
| BMRN | Biomarin Pharmaceutical Inc | 301,605 | $24.99M | 2.1% | $81.66 | -2.5% | COM | 09061G101 |
| — | Reata Pharmaceuticals Inc | 783,851 | $23.82M | 2.0% | $32.21 | — | CL A | 75615P103 |
| VRTX | Vertex Pharmaceuticals Inc | 74,758 | $21.07M | 1.8% | $237.33 | +12.8% | COM | 92532F100 |
| AZN | AstraZeneca PLC | 316,360 | $20.9M | 1.7% | $66.34 | — | SPONSORED ADR | 046353108 |
| RGNX | Regenxbio Inc | 776,624 | $19.18M | 1.6% | $32.39 | -22.9% | COM | 75901B107 |
| — | Inozyme Pharm Inc | 3,655,308 | $17.44M | 1.5% | $16.71 | — | COM | 45790W108 |
| — | CTI Biopharma Corp | 2,704,510 | $16.15M | 1.3% | $5.03 | — | COM | 12648L601 |
| — | ChemoCentryx Inc | 636,659 | $15.78M | 1.3% | $29.02 | — | COM | 16383L106 |
| IRTC | iRhythm Technologies Inc | 142,091 | $15.35M | 1.3% | $132.47 | 0.0% | COM | 450056106 |
| SNY | Sanofi SA | 282,200 | $14.12M | 1.2% | $50.03 | — | SPONSORED ADR | 80105N105 |
| DXCM | Dexcom Inc | 189,092 | $14.09M | 1.2% | $93.06 | -1.9% | COM | 252131107 |
| CYTK | Cytokinetics Inc | 320,780 | $12.6M | 1.0% | $36.75 | +9.6% | COM | 23282W605 |
| — | Nextcure Inc | 2,671,856 | $12.56M | 1.0% | $10.01 | — | COM | 65343E108 |
| IMTX | Immatics NV | 1,294,103 | $11.27M | 0.9% | $11.23 | -29.5% | SHS | N44445109 |
| — | Prometheus Biosciences Inc | 386,395 | $10.91M | 0.9% | $28.23 | — | COM | 74349U108 |
| SRPT | Sarepta Therapeutics Inc | 131,245 | $9.838M | 0.8% | $75.09 | -2.0% | COM | 803607100 |
| ZNTL | Zentalis Pharmaceuticals Inc | 328,397 | $9.228M | 0.8% | $26.49 | 0.0% | COM | 98943L107 |
| — | Horizon Therapeutics PLC | 100,297 | $8M | 0.7% | $108.84 | — | SHS | G46188101 |
| SNDX | Syndax Pharmaceuticals Inc | 413,428 | $7.954M | 0.7% | $17.69 | -5.8% | COM | 87164F105 |
| — | ObsEva SA | 4,749,623 | $7.647M | 0.6% | $13.49 | — | COM | H5861P103 |
| — | Adicet Bio Inc | 518,379 | $7.568M | 0.6% | $17.42 | — | COM | 007002108 |
| — | Akouos Inc | 1,515,074 | $7.106M | 0.6% | $22.50 | — | COM | 00973J101 |
| — | Iveric Bio Inc | 653,047 | $6.282M | 0.5% | $16.58 | — | COM | 46583P102 |
| — | ChemoCentryx Inc | 250,000 | $6.195M | 0.5% | $29.02 | — | Call | 16383L106 |
| ARGX | argenx SE | 15,000 | $5.683M | 0.5% | $378.87 | — | SPONSORED ADR | 04016X101 |
| — | Bolt Biotherapeutics Inc | 2,754,437 | $5.619M | 0.5% | $32.91 | — | COM | 097702104 |
| TVTX | Travere Therapeutics Inc | 212,593 | $5.151M | 0.4% | $24.05 | +4.6% | COM | 89422G107 |
| — | ImmunoGen Inc | 1,140,788 | $5.134M | 0.4% | $7.42 | — | COM | 45253H101 |
| — | Seagen Inc | 27,894 | $4.936M | 0.4% | $176.96 | — | COM | 81181C104 |
| — | Chinook Therapeutics Inc | 276,609 | $4.838M | 0.4% | $17.49 | — | COM | 16961L106 |
| XNCR | Xencor Inc | 158,164 | $4.329M | 0.4% | $37.91 | -34.9% | COM | 98401F105 |
| GERN | Geron Corp | 2,791,630 | $4.327M | 0.4% | $1.21 | +16.8% | COM | 374163103 |
| — | Nucana Biomed | 5,599,999 | $4.06M | 0.3% | $9.47 | — | SPONSORED ADR | 67022C106 |
| GRTX | Galera Therapeutics Inc | 3,083,712 | $4.009M | 0.3% | $12.19 | -86.0% | COM | 36338D108 |
| AMLX | Amylyx Pharmaceuticals Inc | 187,381 | $3.609M | 0.3% | $17.52 | -32.2% | COM | 03237H101 |
| — | Jounce Therapeutics Inc | 981,928 | $2.975M | 0.2% | $7.80 | — | COM | 481116101 |
| — | Agenus Inc | 952,742 | $1.848M | 0.2% | $1.94 | — | COM | 00847G705 |
| — | Nucana Biomed | 2,400,000 | $1.74M | 0.1% | $4.99 | — | Ordinary Shares | GB00BYWYV |
| — | Inhibrx Inc | 147,935 | $1.679M | 0.1% | $37.60 | — | COM | 45720L107 |
| GERN | Geron Corp | 1,000,000 | $1.55M | 0.1% | $1.21 | +16.8% | Call | 374163103 |
| CLDX | Celldex Therapeutics Inc | 48,304 | $1.302M | 0.1% | $29.04 | 0.0% | COM | 15117B202 |
| PTGX | Protagonist Therapeutics Inc | 100,000 | $791K | 0.1% | $27.77 | -56.5% | Call | 74366E102 |
| — | Synlogic Inc | 574,972 | $661K | 0.1% | $9.38 | — | COM | 87166L100 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $521K | 0.0% | $8.36 | -43.1% | COM | 70465T107 |
| — | Fusion Pharmaceuticals Inc | 78,066 | $194K | 0.0% | $7.92 | — | COM | 36118A100 |
| INSM | Insmed Inc | 7,370 | $145K | 0.0% | $28.28 | -25.9% | COM PAR $.01 | 457669307 |